Rice Hall James & Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,370
| Closed | -$240K | – | 262 |
|
|
2022
Q3 | $240K | Sell |
3,370
-100
| -3% | -$7.25K | 0.01% | 260 |
|
|
2022
Q2 | $267K | Sell |
3,470
-100
| -3% | -$7.62K | 0.01% | 258 |
|
|
2022
Q1 | $261K | Sell |
3,570
-300
| -8% | -$20.1K | 0.01% | 289 |
|
|
2021
Q4 | $241K | Hold |
3,870
| – | – | 0.01% | 298 |
|
|
2021
Q3 | $229K | Hold |
3,870
| – | – | 0.01% | 305 |
|
|
2021
Q2 | $259K | Hold |
3,870
| – | – | 0.01% | 294 |
|
|
2021
Q1 | $244K | Hold |
3,870
| – | – | 0.01% | 294 |
|
|
2020
Q4 | $240K | Hold |
3,870
| – | – | 0.01% | 281 |
|
|
2020
Q3 | $233K | Sell |
3,870
-338
| -8% | -$20.3K | 0.01% | 259 |
|
|
2020
Q2 | $247K | Sell |
4,208
-200
| -5% | -$12K | 0.01% | 256 |
|
|
2020
Q1 | $246K | Hold |
4,408
| – | – | 0.01% | 255 |
|
|
2019
Q4 | $283K | Hold |
4,408
| – | – | 0.01% | 260 |
|
|
2019
Q3 | $224K | Buy |
+4,408
| New | +$207K | 0.01% | 266 |
|
|
2019
Q2 | – | Sell |
-4,408
| Closed | -$210K | – | 276 |
|
|
2019
Q1 | $210K | Sell |
4,408
-200
| -4% | -$9.96K | 0.01% | 290 |
|
|
2018
Q4 | $240K | Hold |
4,608
| – | – | 0.01% | 285 |
|
|
2018
Q3 | $286K | Hold |
4,608
| – | – | 0.01% | 287 |
|
|
2018
Q2 | $255K | Hold |
4,608
| – | – | 0.01% | 286 |
|
|
2018
Q1 | $291K | Hold |
4,608
| – | – | 0.01% | 280 |
|
|
2017
Q4 | $282K | Hold |
4,608
| – | – | 0.01% | 286 |
|
|
2017
Q3 | $294K | Sell |
4,608
-180
| -4% | -$10.5K | 0.01% | 277 |
|
|
2017
Q2 | $267K | Sell |
4,788
-800
| -14% | -$43.5K | 0.01% | 277 |
|
|
2017
Q1 | $304K | Sell |
5,588
-700
| -11% | -$38.4K | 0.01% | 282 |
|
|
2016
Q4 | $367K | Hold |
6,288
| – | – | 0.02% | 275 |
|
|
2016
Q3 | $339K | Hold |
6,288
| – | – | 0.02% | 274 |
|
|
2016
Q2 | $462K | Hold |
6,288
| – | – | 0.03% | 258 |
|
|
2016
Q1 | $402K | Hold |
6,288
| – | – | 0.02% | 262 |
|
|
2015
Q4 | $433K | Hold |
6,288
| – | – | 0.02% | 261 |
|
|
2015
Q3 | $372K | Hold |
6,288
| – | – | 0.02% | 275 |
|
|
2015
Q2 | $418K | Sell |
6,288
-300
| -5% | -$19.8K | 0.02% | 275 |
|
|
2015
Q1 | $425K | Hold |
6,588
| – | – | 0.02% | 283 |
|
|
2014
Q4 | $389K | Hold |
6,588
| – | – | 0.02% | 280 |
|
|
2014
Q3 | $337K | Hold |
6,588
| – | – | 0.02% | 274 |
|
|
2014
Q2 | $320K | Hold |
6,588
| – | – | 0.02% | 280 |
|
|
2014
Q1 | $342K | Hold |
6,588
| – | – | 0.03% | 280 |
|
|
2013
Q4 | $350K | Hold |
6,588
| – | – | 0.03% | 277 |
|
|
2013
Q3 | $305K | Hold |
6,588
| – | – | 0.03% | 255 |
|
|
2013
Q2 | $294K | Buy |
+6,588
| New | +$286K | 0.03% | 255 |
|
Other funds holding BMY
Rice Hall James & Associates's BMY Position: Q4 2022 in Review
Rice Hall James & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2022, closing a stake of 3,370 shares — an estimated $240K sold.
Rice Hall James & Associates first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $462K in Q2 2016. 2,602 funds tracked by Wall St. Rank hold BMY as of Q4 2022.
- Rice Hall James & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2022 after selling out during the quarter.
- Rice Hall James & Associates sold 3,370 Bristol-Myers Squibb shares in Q4 2022, an estimated $240K.
- Rice Hall James & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
- Rice Hall James & Associates's Bristol-Myers Squibb position peaked at $462K in Q2 2016.
- 2,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2022.
Based on Rice Hall James & Associates's 13F filing for Q4 2022, filed 27 Jan 2023.